Document is current

Article History

Received: 11 August 2021

Accepted: 12 September 2021

First Online: 15 October 2021

Declarations

:

: Potential conflicts of interest. S. G. and D. H. C. are recipients of investigator-initiated grants to their universities from Pfizer to study pneumococcal vaccines and Sanofi Pasteur and Seqirus to study influenza vaccines. S. G. also does consulting for Seqirus, Sanofi, Merck, Vaxart, Novavax, Novavax and Janssen; has served on the speaker’s bureaus for Seqirus and Sanofi; and reports personal fees from Pfizer and data and safety monitoring board (DSMB) fees from Longevoron. D. H. C. has done consulting work for Seqirus. S. D. B. reports royalties from Wolters-Kluwer, lecture fees from Harvard, and DSMB membership for a trial of zoledronic acid in Parkinson’s patients, outside the submitted work. C. L. K. reports grants from the Bill & Melinda Gates Foundation, the National Institutes of Health, and Veterans Health Administration, outside the submitted work.

: Approval was obtained from the New England Institutional Review Board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

: Informed consent was obtained from all individual participants included in the study.

: The authors affirm that participants provided informed consent for publication of the data generated from their participation in the study.